• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

错配修复蛋白缺陷的浸润性膀胱尿路上皮癌中PD-1和PD-L1的表达状态

Status of PD-1 and PD-L1 expression in invasive urothelial carcinoma of the bladder with mismatch repair protein deficiency.

作者信息

Sungu Nuran, Kıran Merve M

机构信息

Department of Pathology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkey.

Department of Pathology, Ankara City Hospital, Ankara, Turkey.

出版信息

Pol J Pathol. 2023;74(3):161-170. doi: 10.5114/pjp.2023.132221.

DOI:10.5114/pjp.2023.132221
PMID:37955535
Abstract

It has been reported that mismatch repair deficient (d-MMR) tumors show sensitivity to immune checkpoint inhibitors. We aimed to evaluate the correlation of d-MMR and PD-1/PD-L1 expression in invasive urothelial carcinoma of the bladder. Tissue microarray (TMA) tissues were stained PD-1/PD-L1 and MMR proteins. The expression ratio of these markers has been compared with histopathologic parameters. d-MMR tumors were more superficial muscle invasive (p = 0.012). When the d-MMR, and PD-1/PD-L1 expression ratios were examined, a significant correlation was obtained between the d-MMR and PD-L1 expression ratio of > 5% in both the tumor and immune cells (p = 0.02 and p = 0.004, respectively). The expression ratio was higher in the patients without MMR loss. PD-1 and PD-L1expression in those with MSH6 loss was one or none. When PD1/PDL1 expression was compared with histopathological parameters, a significant relationship was observed between tumor grade and depth of muscle invasion. PD-L1 expression was not observed in the superficial muscle invasive tumors. This study was shown the status of d-MMR and PD-1/PD-L1 in invasive urothelial cancers and their correlation with prognostic markers. PD-1/PD-L1 expression may contribute to the progression and poor prognosis of bladder cancer. However, further studies are required to research the clinical utility.

摘要

据报道,错配修复缺陷(d-MMR)肿瘤对免疫检查点抑制剂敏感。我们旨在评估膀胱浸润性尿路上皮癌中d-MMR与PD-1/PD-L1表达的相关性。组织微阵列(TMA)组织进行了PD-1/PD-L1和MMR蛋白染色。这些标志物的表达率与组织病理学参数进行了比较。d-MMR肿瘤更易侵犯浅肌层(p = 0.012)。当检查d-MMR和PD-1/PD-L1表达率时,在肿瘤细胞和免疫细胞中d-MMR与PD-L1表达率>5%之间存在显著相关性(分别为p = 0.02和p = 0.004)。在无MMR缺失的患者中表达率更高。MSH6缺失患者中PD-1和PD-L1表达为1例或无表达。当将PD1/PDL1表达与组织病理学参数进行比较时,观察到肿瘤分级与肌层浸润深度之间存在显著关系。在浅肌层浸润性肿瘤中未观察到PD-L1表达。本研究显示了浸润性尿路上皮癌中d-MMR和PD-1/PD-L1的状态及其与预后标志物的相关性。PD-1/PD-L1表达可能促进膀胱癌的进展和预后不良。然而,需要进一步研究以探讨其临床应用价值。

相似文献

1
Status of PD-1 and PD-L1 expression in invasive urothelial carcinoma of the bladder with mismatch repair protein deficiency.错配修复蛋白缺陷的浸润性膀胱尿路上皮癌中PD-1和PD-L1的表达状态
Pol J Pathol. 2023;74(3):161-170. doi: 10.5114/pjp.2023.132221.
2
Correlation of mismatch repair protein deficiency, PD-L1 and CD8 expression in high-grade urothelial carcinoma of the bladder.高级别膀胱尿路上皮癌中错配修复蛋白缺陷、PD-L1 和 CD8 表达的相关性。
J Clin Pathol. 2020 Aug;73(8):519-522. doi: 10.1136/jclinpath-2019-206256. Epub 2020 Jan 9.
3
Role of PD-1/PD-L1-mediated tumour immune escape mechanism and microsatellite instability in the BCG failure of high-grade urothelial carcinomas.PD-1/PD-L1 介导的肿瘤免疫逃逸机制和微卫星不稳定性在卡介苗治疗高级别尿路上皮癌失败中的作用。
Turk J Med Sci. 2022 Dec;52(6):1802-1813. doi: 10.55730/1300-0144.5526. Epub 2022 Dec 21.
4
PD-L1 Expression in Mismatch Repair-deficient Endometrial Carcinomas, Including Lynch Syndrome-associated and MLH1 Promoter Hypermethylated Tumors.PD-L1 表达在错配修复缺陷型子宫内膜癌中的作用,包括 Lynch 综合征相关和 MLH1 启动子高甲基化肿瘤。
Am J Surg Pathol. 2017 Mar;41(3):326-333. doi: 10.1097/PAS.0000000000000783.
5
Clinicopathological characteristics, molecular landscape, and biomarker landscape for predicting the efficacy of PD-1/PD-L1 inhibitors in Chinese population with mismatch repair deficient urothelial carcinoma: a real-world study.中国人群中错配修复缺陷型尿路上皮癌的临床病理特征、分子谱和生物标志物谱与 PD-1/PD-L1 抑制剂疗效预测的相关性:一项真实世界研究。
Front Immunol. 2023 Nov 6;14:1269097. doi: 10.3389/fimmu.2023.1269097. eCollection 2023.
6
The Relationship Between Mismatch Repair Deficiency and PD-L1 Expression in Breast Carcinoma.错配修复缺陷与乳腺癌中 PD-L1 表达的关系。
Am J Surg Pathol. 2018 Feb;42(2):183-191. doi: 10.1097/PAS.0000000000000949.
7
Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.高级别 T1 期与肌层浸润性膀胱癌中 PD-L1 的差异表达及其预后意义。
J Urol. 2017 Oct;198(4):817-823. doi: 10.1016/j.juro.2017.04.102. Epub 2017 May 6.
8
Correlation between messenger RNA expression and protein expression of immune checkpoint-associated molecules in bladder urothelial carcinoma: A retrospective study.膀胱尿路上皮癌中免疫检查点相关分子的信使核糖核酸表达与蛋白质表达的相关性:一项回顾性研究。
Urol Oncol. 2017 May;35(5):257-263. doi: 10.1016/j.urolonc.2017.01.014. Epub 2017 Mar 11.
9
Programmed death-ligand 1 expression in gastric cancer: correlation with mismatch repair deficiency and HER2-negative status.程序性死亡配体 1 在胃癌中的表达:与错配修复缺陷和 HER2 阴性状态的相关性。
Cancer Med. 2018 Jun;7(6):2612-2620. doi: 10.1002/cam4.1502. Epub 2018 Apr 19.
10
Correlation of mismatch repair deficiency with clinicopathological features and programmed death-ligand 1 expression in thyroid carcinoma.错配修复缺陷与甲状腺癌临床病理特征及程序性死亡配体 1 表达的相关性。
Endocrine. 2022 Jun;76(3):660-670. doi: 10.1007/s12020-022-03031-w. Epub 2022 Apr 2.

引用本文的文献

1
The Expression of Programmed Cell Death Ligand-1 and its Relationship with Infiltration, Metastasis and Prognosis in Cervical Squamous Cell Carcinoma.程序性细胞死亡配体-1在宫颈鳞状细胞癌中的表达及其与浸润、转移和预后的关系
Reprod Sci. 2025 May;32(5):1676-1684. doi: 10.1007/s43032-024-01784-5. Epub 2025 Jan 30.